Prospective evaluation of integrated device diagnostics for heart failure management: results of the TRIAGE‐HF study

Abstract

AimsThe primary aim of the TRIAGE‐HF trial was to correlate cardiac implantable electronic device‐generated heart failure risk status (HFRS) with signs, symptoms, and patient behaviours classically associated with worsening heart failure (HF).Methods and resultsTRIAGE‐HF enrolled 100 subjects with systolic HF implanted with a Medtronic high‐performance device and followed up at three Canadian HF centres. Study follow‐up was up to 8 months. The HFRS assigned each subject's overall risk of HF hospitalization in the next 30 days and also highlighted abnormal device parameters contributing to a patient's risk status at the time of remote data transmission. Subjects with a high HFRS were contacted by telephone to assess symptoms, and compliance with prescribed therapies, nutrition, and exercise. Clinician‐assessed risk and HFRS‐calculated risk were correlated at both study baseline and exit. Twenty‐four high HFRS occurrences were observed among 100 subjects. Device parameters associated with increased risk of HF hospitalization included OptiVol index (n = 20), followed by low patient activity (n = 18) and elevated night heart rate (n = 12). High HFRS was associated with symptoms of worsening HF in 63% of cases (n = 15) increasing to 83% of cases (n = 20) when non‐compliance with pharmacological therapies and lifestyle was considered.ConclusionsTRIAGE‐HF is the first study to provide prospective data on the distribution of abnormal device parameters contributing to high HFRS. High HFRS has good predictive accuracy for patient‐reported signs, symptoms, and behaviours associated with worsening HF status. As such, HFRS may be a useful tool for ambulatory HF monitoring to improve both patient‐centred and health system level outcomes.

Do ICD diagnostics predict failure of ventricular tachycardia response to antitachycardia pacing and need for shock?

“…Previous literature has showed that the integrated ICD diagnostics included in our study, individually and in combination, were able to identify patients at risk of adverse outcomes such as heart failure hospitalization and mortality. [18][19][20][21][22][23] The specific ICD physiological parameters employed in the current study were selected given their strongest effect on clinical outcomes based on prior research. 24 Catanzariti et al showed monitoring thoracic impedance reduced hospitalization related to heart failure.…”

Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care

“…Detection of asymptomatic deterioration would effectively take the place following a physical examination performed in the clinic and may involve the use of simple measures such as weight and blood pressure, but may also expand in suitable patients to involve more advanced metrics such as implantable sensor data (e.g. CardioMEMS™ [50], OptiVol™ [63]). Effective monitoring may be improved by novel eHealth technology and sensors, which is a rapidly growing field.…”

Remote Management of Heart Failure: An Overview of Telemonitoring Technologies

“…The Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure (PARTNERS HF) and Integrated Diagnostic for Heart Failure (TRIAGE-HF) trials have shown promise in identifying which patients are at risk of hospitalisation. [28,29]…”